169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Methods of disease activity profiling for personalized therapy management
#2102Pharmaceutical composition comprising IL-34 and a mTOR inhibitor
#2103Immune-modifying nanoparticles for the treatment of inflammatory diseases
#2104Pirfenidone Treatment for Patients with Atypical Liver Function
#2105METHODS OF TREATING AUTOPHAGY-ASSOCIATED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS
#2106STOOL SPECIMEN COLLECTING, SAMPLING AND DIAGNOSING MEANS AND METHODS THEREOF
#2107METHODS AND COMPOSITIONS FOR DETERMINING FORTILIN LEVELS
#2108Systemic immune activation and biomarkers of nonceliac wheat/gluten sensitivity
#2109System for detecting infection in synovial fluid
#2110ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#2111Systems and methods to diagnose sarcoidosis and identify markers of the condition
#2112Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients
#2113Anti-mesothelin binding proteins
#2114Anti-tenascin C antibodies and uses thereof
#2115Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
#2116BIOMARKER FOR USE IN TREATING ANEMIA
#2117COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#2118Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy
#2119Kit for a Determination Method for Calprotectin and the Use of Calprotectin as a Predictive Marker for Cardiovascular Disease
#2120Methods for monitoring immune status of a subject
#2121OMA1 activity assay
#2122COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
#2123Compositions and methods for neuralgenesis
#2124Predicting mortality and detecting severe disease
#2125Antibodies which specifically bind αKlotho polypeptide
#2126MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS
#2127Binding assay for the diagnosis of a heparin-induced thrombocytopenia
#2128Salivary mRNA Profiling, Biomarkers and Related Methods and Kits of Parts
#2129Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies
#2130Probiotics strains for treating and/or preventing diarrhea
#2131Antibodies against N-acetylglucosamine and N-acetyl-galactosamine
#2132Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease
#2133RENAL FUNCTION EVALUATING DEVICE, DEVICE FOR PREDICTING ONSET OF KIDNEY DISEASE COMPLICATIONS, AND PHOSPHOROUS INGESTION AMOUNT ESTIMATING DEVICE
#2134Process for in vitro diagnosis of hepatic disorders
#2135Detection of angiopoietin-2 and thrombospondin-2 in connection with diagnosing acute heart failure
#2136Multiplex MRM assay for evaluation of cancer
#2137Predictive methods of atherosclerosis and stenosis
#2138Compositions and methods for detecting, treating and preventing diseases and disorders
#2139Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof
#2140TROPONIN I AND SOLUBLE UROKINASE RECEPTOR DETECTION FOR DETERMINING THE RISK OF CARDIOVASCULAR DISEASE
#2141Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#2142Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#2143Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#2144Methods for Early Diagnosis of Kidney Disease
#2145Method for diagnosing disseminated intravascular coagulation (DIC)
#2146Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof
#2147GDF15 in glaucoma and methods of use thereof
#2148METHODS AND KITS OF ASSESSING STATUS, RISK OR PROGNOSIS OF TYPE 1 DIABETES
#2149Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections
#2150Anti-adrenomedullin (ADM) monoclonal antibodies and anti-ADM monoclonal antibody fragments that bind to adrenomedullin
#2151Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#2152Methods of treating liver fibrosis
#2153BIOMARKERS FOR STROKE
#2154Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis
#2155Method to predict response to pharmacological chaperone treatment of diseases
#2156Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
#2157Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection through the measurement of lysophosphatidic acid
#2158Methods and systems for analysis of organ transplantation
#2159Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers
#2160LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#2161Biomarkers of vascular disease
#2162IGFBP-7 as a marker of preeclampsia
#2163Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#2164THERAPEUTIC AND DIAGNOSTIC MOLECULES
#2165Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#2166BONE ACTIVE NITROGEN-CONTAINING BISPHOSPHONATES WITH A NEAR INFRARED FLUORESCENT LABEL
#2167Isobaric mass labels having n',n'-dimeihyl piperazine-2-carboxylic acid reporter moieties
#2168MARKERS FOR CORONARY ARTERY DISEASE AND USES THEREOF
#2169Methods and kits for monitoring membranous nephropathy
#2170Activation assay for the diagnosis of a heparin-induced thrombocytopenia
#2171URINE BIOMARKERS FOR DETECTING GRAFT REJECTION
#2172Method for determining fat free body mass
#2173Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment
#2174Methods for treating sarcopenia and frailty
#2175Mutations in rhodopsin gene in zebrafish and uses thereof
#2176Methods for diagnosing and treating inflammatory bowel disease
#2177Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
#2178Methods and Compositions For the Treatment of Proteinuric Diseases
#2179Minimally-invasive measurement of esophageal inflammation
#2180MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8 REGULATES FATTY ACID UPTAKE
#2181Biomarker of polycystic kidney disease and uses thereof
#2182Methods of quantifying N-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG
#2183Methods for enabling pet ownership
#2184METHODS FOR PREDICTING RISK OF DEVELOPING HYPERTENSION
#2185Diagnostics and Therapeutics for Macular Degeneration-Related Disorders
#2186Compositions useful in the diagnostic of latently infected
#2187Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#2188Compositions and methods to detect non-coeliac gluten sensitivity
#2189C-CBL mutations and uses thereof
#2190Methods for the diagnosis of fetal abnormalities
#2191Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus
#2192Methods to Diagnose, Treat and Prevent Bone Loss
#2193Pathway specific markers for diagnosing irritable bowel syndrome
#2194Exosomal Protein Profiling for Detection of Cardiac Transplant Rejection
#2195USE OF CD146 AS A MARKER OF THE VASCULAR WALL TENSION
#2196Soluble MANF in pancreatic beta-cell disorders
#2197VIRAL BIOMARKERS AND USES THEREFOR
#2198Biomarker panel for dose assessment of radiation injury and micro plasma filter
#2199Methods of detection and treatment for cardiovascular disease and foot wounds
#2200PEPTIDES AND METHODS OF TREATING ENDOMETRIOSIS USING THE SAME
#2201Method of determining protein expression
#2202Method, array and use thereof
#2203Marker for determining diabetic nephropathy
#2204DIAGNOSTIC TESTING FOR IMMUNOLOGIC FOOD SENSITIVITY IN ANIMALS
#2205Cartridge for diagnostic testing
#2206METHOD AND IDENTIFICATION KIT FOR IDENTIFYING CAUSATIVE DRUG FOR DRUG HYPERSENSITIVITY REACTION
#2207Use of a Neuregulin to Treat Peripheral Nerve Injury
#2208METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION
#2209DESETHYLHYDROXYCHLOROQUINE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATION
#2210Method for the in vitro diagnosis of thyroid diseases
#2211Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#2212Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
#2213Immunoassay to detect cleaved high molecular weight kininogen
#2214Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries
#2215METHODS FOR IMPROVING DIABETES MANAGEMENT
#2216Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#2217Pathogen biomarkers and uses therefor
#2218BIOMARKER FOR DIAGNOSIS OF DRUG ADDICTION AND KIT FOR DIAGNOSIS OF DRUG ADDICTION
#2219Chip for detecting allergy, manufacturing method thereof and a method for detecting allergy using therefor
#2220Methods for detection of emphysema
#2221Method for Diagnosing Lactation Sufficiency
#2222Role of citrullination in diagnosing diseases
#2223Diagnostic testing for immunologic food sensitivity
#2224CYTOTOXIC T CELL RESPONSE MODIFIERS
#2225Compositions and methods for the treatment of fatty acid metabolism disorders
#2226METHODS FOR TREATING CARDIAC INJURY
#2227Peptides and method for treatment of cardiac arrest
#2228Treatment using chimeric receptor T cells incorporating optimized polyfunctional T cells
#2229Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#2230Device and method for detection of analytes
#2231S100A9 levels for predicting lenalidomide and erythropoietin responsiveness
#2232PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
#2233Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
#2234GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS
#2235Portable insulin resistance diagnosis device and diagnosis method using same
#2236Nanovesicles, methods, and systems for diagnosis and prognosis of cancer
#2237Compositions and methods for identifying and treating dystonia disorders
#2238COMPOSITIONS AND METHODS FOR IDENTIFYING, MODULATING AND MONITORING DRUG TARGETS IN MUSCULAR DISEASE
#2239Periostin fragments and use thereof
#2240DETECTION OF ACUTE MYOCARDIAL INFARCTION
#2241KITS FOR STRATIFYING SCOLIOTIC SUBJECTS
#2242Device and methods of using device for detection of hyperammonemia
#2243Biomarkers for assessing subjects with multiple sclerosis
#2244Lung cancer biomarkers and uses thereof
#2245Markers for inflammatory bowel disease
#2246Compositions and methods for treatment of lung function
#2247OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE
#2248Methods for predicting and treating patients with increased risk of adverse pregnancy outcome
#2249Biomarkers for use in prognosis of mortality in critically ill patients
#2250Dosage regimen for MAdCAM antagonists
#2251Humanized or affinity-matured anti ang-2 antibody and uses thereof
#2252Method for purifying pure thioflavin T, method for producing pure thioflavin T, composition including thioflavin T, and amyloid detection method
#2253Methods for treating diseases mediated by ErbB4-positive pro-inflammatory macrophages
#2254Compositions and methods for identifying and treating dystonia disorders
#2255Biochemical Markers for Pulmonary and Other Diseases
#2256Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (CLL) and/or of systemic lupus erythematosus (SLE) using membrane STIM 1
#2257Biomarkers for Diagnosing Liver Disease
#2258Methods for diagnosing and evaluating non-alcoholic steatohepatitis
#2259MOLECULAR METHODS FOR ASSESSING POST KIDNEY TRANSPLANT COMPLICATIONS
#2260THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR FLAVIVIRUSES
#2261Buccal cell diagnosis of arrhythmogenic cardiomyopathy (ACM)
#2262Method for the diagnosis of Gaucher's disease
#2263Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
#2264Method for assaying lower respiratory tract infection or inflammation
#2265Methods for identifying patterns of IFN induced expression and use in diagnosis, monitoring and therapy
#2266Multiple hybrid immunoassay
#2267Methods for detecting analytes
#2268Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#2269Selection of agents modulating gastrointestinal pain
#2270Therapeutic and imaging compositions and uses thereof
#2271Antibodies to human erythroferrone and uses thereof
#2272Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
#2273Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists
#2274Non-human animal models of retinoschisis
#2275METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#2276Disease-state biomarker for renal disease
#2277Biomarkers predictive of cytokine release syndrome
#2278Microparticle fractionation
#2279Modulation of splenocytes in cell therapy
#2280Health test for a broad spectrum of health problems
#2281Method for detecting plasminogen activator inhibitor-1 in a sample
#2282A COMPOSITION COMPRISING PROSTACYCLIN ANDOR ANALOGUES THEREOF FOR TREATMENT OF ACUTE CRITICALLY ILL PATIENTS
#2283USE OF ODAM AS PARADENTAL DISEASE BIOMARKER
#2284Biodosimetry panels and methods
#2285NOVEL ANTIBODY AGAINST RIBOSOMAL PROTEIN S3 AND COMPOSITION FOR DIAGNOSING BIOLOGICAL STRESS
#2286Composition for diagnosing, preventing, or treating vascular smooth muscle cell proliferative diseases using FGF12
#2287Inhibitor of IGFBP3/TMEM219 axis and diabetes
#2288MEANS AND METHODS FOR DIAGNOSING CARDIAC DISEASE IN A SUBJECT
#2289Apparatus and Method to Determine Stroke Subtype
#2290Method for evaluating the possibility of suffering from pancreatic disease
#2291METHODS AND COMPOSITIONS FOR DIAGNOSIS OF ECTOPIC PREGNANCY
#2292Immune checkpoint molecular fitness profiling by mass spectrometry
#2293METHODS FOR USING ANTIBODIES AND ANALOGS THEREOF
#2294Fluid actuation of instruments through a sterile barrier
#2295METHODS FOR DETECTION OF DEPRESSIVE DISORDERS
#2296Therapeutic Agents
#2297Predicting risk of major adverse cardiac events
#2298Detection and treatment of LRP4-associated neurotransmission disorders
#2299IGFBP7 for prediction of risk of AKI when measured prior to surgery
#2300AFFINITY CAPTURE OF CIRCULATING BIOMARKERS
#2301Antibody to cytolethal distending toxin of
#2302METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#2303METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF APPENDICITIS AND DIFFERENTIATION OF CAUSES OF ABDOMINAL PAIN
#2304Endothelial cell derived exosomes and uses thereof
#2305METHOD OF PREDICTING AND DETERMINING THERAPEUTIC EFFECT ON RHEUMATOID ARTHRITIS DUE TO BIOLOGICAL FORMULATION
#2306DETECTION OF GLUTATHIONYLATED PROTEINS
#2307Method for examining renal disease
#2308Methods and products related to glutaminase inhibitors
#2309Biomarkers of myocardial injury
#2310IL1RL-1 as a cardiovascular disease marker and therapeutic target
#2311Devices and methods for diagnosis of sinusitis
#2312Biomarkers and methods for assessing psoriatic arthritis disease activity
#2313Protein Damage in Aging and Age-Related Diseases
#2314Measurement method and measurement device
#2315TEST FOR MONITORING RENAL DISEASE
#2316Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker
#2317MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS
#2318USES OF LP-PLA2 IN COMBINATION TO ASSESS CORONARY RISK
#2319Methods and compositions for treatment of autoimmune hepatitis
#2320ANALYSIS FOR ATHEROSCLEROSIS
#2321Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2322Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#2323Three-dimensional co-culture method for adipocytes and macrophages
#2324Anti-GPNMB antibodies and diagnostic uses thereof
#2325Method for decreasing depression-like behavior with connective tissue growth factor (CTGF) inhibitor
#2326NON-ALCOHOLIC FATTY LIVER REGULATING FACTOR 14-3-3 PROTEIN
#2327Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
#2328Method for the diagnosis of Farber's disease
#2329Biomarkers to improve prediction of heart failure risk
#2330Biomarkers Related to Insulin Resistance Progression and Methods Using the Same
#2331Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile and spreading
#2332Anti-presepsin antibody
#2333Anti-transthyretin antibodies
#2334Pirfenidone Treatment for Patients with Atypical Liver Function
#2335Angiopoietin-like 4 and a method of its use in wound healing
#2336Troponin and BNP based diagnosis of risk patients and cause of stroke
#2337Method of determinig levels of anti-vinculin and anti-cytolethal distending toxin antibodies in subjects desiring to distinguish irritable bowel syndrome from inflammatory bowel disease
#2338Thyroglobulin quantitation by mass spectroscopy
#2339Cystic fibrosis transmembrane conductance regulator gene mutations
#2340Therapeutic regimen for hypertension
#2341Compositions and methods for determining genetic polymorphisms in the TMEM216 gene
#2342Method for the diagnosis of disorders caused by fetal alcohol syndrome
#2343Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#2344Nanocarriers and their processing for diagnostics and therapeutics
#2345DIAGNOSTIC METHODS FOR LIVER DISORDERS
#2346Cardiomyocyte-Specific Biological Markers and Uses Thereof
#2347Cardiovascular risk event prediction and uses thereof
#2348Diagnostic blood test for sarcoidosis
#2349METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#2350Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
#2351Ligand binding assays using MALDI-TOF mass spectrometry
#2352Red blood cell dynamics for gastrointestinal evaluation
#2353Directed evolution through mutation rate modulation
#2354Modulation of epigenetic stress response
#2355Predicting suicidality using a combined genomic and clinical risk assessment
#2356Method and apparatus for monitoring the state of health of dairy cows
#2357Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
#2358Methods for treating inflammatory bowel disease
#2359Biomarker for predicting the sensitivity to a protein kinase inhibitor and a use thereof
#2360Isolated Organ Evaluation and Treatment
#2361SMALL MOLECULE INHIBITORS OF GP120-MEDIATED HIV INFECTION AND METHODS OF USE
#2362Methods and devices for rapid assessment of severity of injury
#2363Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases
#2364DIAGNOSTIC TARGET
#2365Devices and assays for diagnosis of sinusitis
#2366Affinity Plate for Haptoglobin Phenotype Determination, Kit Comprising It, and Method of Haptoglobin Phenotype Determination by Means of Affinity Plates in Combination with Desorption Ionization Mass Spectrometry Techniques
#2367Variant libraries of the immunological synapse and synthesis thereof
#2368Reaction mixtures for diagnosing bacterial vaginosis
#2369Prostate cancer-associated secreted proteins
#2370Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure
#2371METHOD AND DEVICE FOR TESTING RENAL FUNCTION USING URINARY VEGF-A165b AS INDICATOR, AND PROGRAM AND RECORDING MEDIUM FOR CAUSING TO FUNCTION AS DEVICE FOR TESTING RENAL FUNCTION
#2372Biomarkers for the detection of acute rejection in heart transplantation
#2373Inflammasome activation in myelodysplastic syndromes
#2374Methods of diagnosing infection or recurrence in a subject
#2375Sortilin 1 is a novel inducer of vascular calcification
#2376Compositions and methods for controlling vasculature
#2377CD137 binding fibronectin type III domains
#2378METHOD FOR ASSISTING DIAGNOSIS OF CONDITIONS OF MYELOFIBROSIS
#2379KIDNEY FUNCTION BIOMARKERS
#2380METHODS OF DETERMINING RISK OF CARDIAC ARRHYTHMIA
#2381BIOMARKER FOR CARDIAC DISORDERS
#2382TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS
#2383OBSTRUCTIVE SLEEP APNEA (OSA) BIOMARKER PANEL
#2384METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#2385Diagnosis of chronic fatigue diseases using detection antibodies directed against a β-adrenergic receptor
#2386Signal amplification in lateral flow and related immunoassays
#2387Biomarkers for determining the clinical response to cell therapy
#2388NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS
#2389Diagnosis of asthma versus chronic obstructive pulmonary disease (COPD) using urine metabolomic analysis
#2390Kit for detecting target material and method of detecting target material using the same
#2391Methods, devices, kits and compositions for detecting roundworm, whipworm and hookworm
#2392Compositions and methods for the diagnosis of lyme disease
#2393ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF
#2394Diagnostic of heart failure
#2395METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT
#2396CXCL10 AS PREDICTIVE BIOMARKER OF RENAL TRANSPLANT ACUTE REJECTION AND DIAGNOSTIC BIOMARKER OF ANTIBODY-MEDIATED REJECTION (ABMR)
#2397BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN FEMALE SUBJECTS
#2398DETERMINATION OF A MIDREGIONAL PROADRENOMEDULLIN PARTIAL PEPTIDE IN BIOLOGICAL FLUIDS FOR DIAGNOSTIC PURPOSES, AND IMMUNOASSAYS FOR CARRYING OUT SUCH A DETERMINATION
#2399Methods for Detection of Biological Substances
#2400Specific Detection of Clusterin Isoforms